April 20 - 21, 2021
| Chairs: | Gargi Maheshwari (BMS, USA) |
|---|---|
| Barry Buckland (BiologicB, USA) | |
| Tim Charlebois (Pfizer, USA) | |
| Jamey Young (Vanderbilt University) |
The articles for these proceedings are not peer-reviewed.
Please click on the title to view the presentation on your web browser. Please click on the File icon next to the title to download the presentation.
April 20 Introduction, Gargi Maheshwari and Barry Buckland (Video)
Development and Manufacturing of a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs, Alexander (Sandy) Douglas and Raghavan Venkat (Video)
Developing protein based subunit vaccines as a rapid pandemic response – are they fast enough?, Trent Munro (Video)
CMC initiatives to secure global access for vaccines, Ingrid Kromann (Video)
April 20 Closing Remarks, Gargi Maheshwari and Barry Buckland (Video)
April 21 Introduction, Tim Charlebois and Jamey Young (Video)
SARS-CoV-2 replication and targets for countermeasures, Mark Denison (Video)
Combating COVID-19: Identifying a potential drug candidate for human testing in 90 days, Bo Barnhart (Video)
Delivering therapeutic mAbs for covid-19: What can be done in just one year?, Kristen Douglas (Video)
From DNAs to INDs in 3- 6 months for COVID-19 neutralizing antibodies, Weichang Zhou (Video)
April 21 Closing Remarks, Tim Charlebois and Jamey Young (Video)